Business

Pelthos Therapeutics to Report Third Quarter 2025 Financial Results on November 13, 2025

Company to hold a conference call at 8:00 a.m. ETDURHAM, N.C., Nov. 05, 2025 (GLOBE NEWSWIRE) -- Pelthos Therapeutics Inc. (NYSE American: PTHS), a biopharmaceutical company committed to commercializing innovative therapeutic products for unmet patient needs (“Pelthos”), will hold a conference call on Thursday, November 13, 2025, at 8:00 a.m. Eastern Time to discuss its results for the third quarter period ended September 30, 2025. The financial results will be issued in a press release prior to

articlePelthos Therapeutics Inc.November 5, 20251/company/pelthos-therapeutics-inc/news/pelthos-therapeutics-to-report-third-quarter-2025-financial-results-on-november-13-2025
Pelthos Therapeutics to Report Third Quarter 2025 Financial Results on November 13, 2025

About this update from Pelthos Therapeutics Inc.

[{"type":"image","alt":"Pelthos Therapeutics, Inc.","displaySize":"","headline":null,"caption":"Pelthos Therapeutics, Inc.","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":179,"url":"https://media.zenfs.com/en/globenewswire.com/f94dd4c648565b20de109cac2516c355"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/yWW833l91CiuD7s17uRPhw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTI1MTtjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/f94dd4c648565b20de109cac2516c355","width":300,"height":179}},"lazy":false},{"type":"text","content":"Company to hold a conference call at 8:00 a.m. ET","length":49,"tagName":"p"},{"type":"text","content":"DURHAM, N.C., Nov. 05, 2025 (GLOBE NEWSWIRE) -- Pelthos Therapeutics Inc. (NYSE American: PTHS), a biopharmaceutical company committed to commercializing innovative therapeutic products for unmet patient needs (“Pelthos”), will hold a conference call on Thursday, November 13, 2025, at 8:00 a.m. Eastern Time to discuss its results for the third quarter period ended September 30, 2025. The financial results will be issued in a press release prior to the call.","length":461,"tagName":"p"},{"type":"text","content":"Pelthos management will host the call, followed by a question-and-answer period. Details for the conference call can be found below:","length":132,"tagName":"p"},{"type":"table","headerItems":[],"items":[{"val":[{"style":"max-width:14%;width:14%;min-width:14%;text-align:left;vertical-align:middle;vertical-align:top;","val":[{"type":"text","content":"Date:Time:Toll Free:International:Conf.ID:","length":46,"tagName":"p","attribs":{}}]},{"style":"max-width:86%;width:86%;min-width:86%;text-align:left;vertical-align:middle;vertical-align:top;","val":[{"type":"text","content":"Thursday, November 13, 20258:00 a.m. Eastern Time1-877-451-61521-201-389-087913756828","length":89,"tagName":"p","attribs":{}}]}]},{"val":[{"style":"text-align:left;vertical-align:middle;vertical-align:top;","val":[{"type":"text","content":" ","length":6,"tagName":"p","attribs":{}}]},{"style":"text-align:left;vertical-align:middle;vertical-align:top;","val":[{"type":"text","content":" ","length":6,"tagName":"p","attribs":{}}]}]}],"length":137},{"type":"text","content":"Webcast:        https://viavid.webcasts.com/starthere.jsp?ei=1740524&tp_key=723fef088c","length":13...

More updates from Pelthos Therapeutics Inc.

Pelthos Therapeutics Inc.biopharmaceutical company